Skip to search formSkip to main contentSkip to account menu

OPC 21268

Known as: Acetamide, N-(3-(4-((4-(3,4-dihydro-2-oxo-1(2H)-quinolinyl)-1-piperidinyl)carbonyl)phenoxy)propyl)-, OPC-21268 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
1999
1999
OBJECTIVE Recent experimental evidence suggests that centrally released arginine vasopressin plays a significant role in brain… 
Highly Cited
1994
Highly Cited
1994
Rapid right ventricular pacing could induce congestive heart failure in conscious dogs with significant increase in plasma… 
Highly Cited
1994
Highly Cited
1994
To examine whether expression and distribution of aquaporin of collecting duct (AQP-CD) are regulated by vasopressin V2 receptor… 
Highly Cited
1993
Highly Cited
1993
SR 49059, a new potent and selective orally active, nonpeptide vasopressin (AVP) antagonist has been characterized in several in… 
1992
1992
An orally effective, nonpeptide vasopressin V1 receptor antagonist, OPC-21268 was produced for possible human use. We… 
Highly Cited
1991
Highly Cited
1991
An orally effective, nonpeptide, vasopressin V1 receptor antagonist, OPC-21268, has been identified. This compound selectively…